Vaccination

Moderna Commercial Expansion Accelerates Vaccine Launches

Yuvraj — Thu, 18 Jun 2026 10:26:16 +0000

Moderna is strengthening its commercial leadership and operational structure as it prepares for a series of anticipated vaccine launches over the next several years. The company expects potential introductions of its mRNA-based seasonal flu vaccine, combined flu/COVID-19 vaccine, and norovirus vaccine between 2027 and 2028. As part of this effort, Moderna has appointed Esther Banque, […]

The post Moderna Commercial Expansion Accelerates Vaccine Launches first appeared on World Pharma Today.

SK Bioscience Inks Colombia Vaccine Localization Deal

Yuvraj — Wed, 27 May 2026 06:14:15 +0000

In a critical step for Colombia vaccine localization, SK Bioscience will execute a vaccine technology transfer with Colombia’s state-owned pharmaceutical enterprise, VECOL. The partnership focuses on building a local manufacturing site to align with the country’s national vaccine localization initiative. The agreement supports a broader state initiative jointly led by VECOL, the Colombian Ministry of […]

The post SK Bioscience Inks Colombia Vaccine Localization Deal first appeared on World Pharma Today.

Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy

Yuvraj — Wed, 27 May 2026 05:29:27 +0000

After a seven-year absence from the sector, Eli Lilly is returning to the field through a trio of corporate purchases valued at more than $3.8 billion. This infectious disease M&A activity secures Curevo, LimmaTech Biologics, and Vaccine Company, firmly positioning the pharmaceutical organization within the vaccine development arena. The transactions represent a deliberate return to […]

The post Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy first appeared on World Pharma Today.

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

Yuvraj — Mon, 29 Dec 2025 09:53:29 +0000

The French pharma giant, Sanofi, has started a $15.50 per share cash tender offer when it comes to Emeryville, California-based vaccine developer Dynavax, which already goes on to market an adult vaccine that protects against the hepatitis B virus – HBV called Heplisav-B, sales of which came in at almost $95 million in the third […]

The post Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal first appeared on World Pharma Today.

Largest Vaccine Manufacturing Facility in Egypt Launched

Yuvraj — Wed, 24 Dec 2025 05:10:33 +0000

Egypt has gone on to mark quite a prominent milestone when it comes to its biopharmaceutical development by laying the foundation stone for the GENNVAX vaccine manufacturing facility, which is all set to become the largest fully integrated vaccine production complex across the Middle East and Africa. The project goes on to represent a strategic […]

The post Largest Vaccine Manufacturing Facility in Egypt Launched first appeared on World Pharma Today.

Onshoring of Drug Product Manufacturing to Massachusetts

Yuvraj — Tue, 25 Nov 2025 13:30:19 +0000

Moderna is set to expand its US manufacturing capabilities through the onshoring of drug product manufacturing to its present Moderna Technology Center – MTC located Norwood, Massachusetts, in a move that involves an investment of over $140m. By way of this onshoring, the company is now going to operate complete end-to-end mRNA medicine manufacturing throughout the country. It […]

The post Onshoring of Drug Product Manufacturing to Massachusetts first appeared on World Pharma Today.

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Yuvraj — Wed, 22 Oct 2025 07:12:45 +0000

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi. Demonstrates Recipharm’s agility and flexibility, completing full tech transfer, scale-up and process optimisation within three months. Strengthens Recipharm’s position as a trusted partner for innovative and global health collaboration, supporting the development of scalable, affordable vaccines for unmet medical needs. […]

The post Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON first appeared on World Pharma Today.

Nipah Virus Vaccines Enter Clinical Trials in Bangladesh

Yuvraj — Tue, 22 Jul 2025 10:40:27 +0000

Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have demonstrated the ability to treat and prevent infection. While Nipah case numbers remain low, climate change is shifting habitats, bringing fruit bats that transmit and spread the virus in South and […]

The post Nipah Virus Vaccines Enter Clinical Trials in Bangladesh first appeared on World Pharma Today.

Asia’s Bio Sovereignty: Nations Reclaiming Biologics Control

Yuvraj — Mon, 02 Jun 2025 13:28:03 +0000

The biopharmaceutical industry in the Asia-Pacific area has seen a significant strategic shift in recent years; this trend is now commonly acknowledged as Asia’s bio sovereignty movement. Countries like China, India, Japan, South Korea, and Singapore are making daring moves to regain control over the manufacturing, regulation, and distribution of these essential treatments, driven by […]

The post Asia’s Bio Sovereignty: Nations Reclaiming Biologics Control first appeared on World Pharma Today.